Persevere Therapeutics

Seed
perseveretherapeutics.com Biotech & Healthcare Berwyn, United States
Total Funding $1.5M
Latest Round $1.5M Seed
Last Announced Mar 3, 2026
Investors Undisclosed
Decision Makers 1 Verified

About Persevere Therapeutics

Persevere Therapeutics is a clinical-stage pharmaceutical company that develops novel therapeutics for effective cancer treatments.

Company Details

Intelligence Dossier

Corporate & Operational Profile

Primary Industry Biotech & Healthcare
Funding Stage Seed
Global Headquarters Berwyn, United States
Tracked Since Oct 2, 2026

Web & Domain Identity

Domain Registered Date Jan 9, 2025

Social & Network Presence

X / Twitter Profile @PersevereTx (2.0K followers) Created on Oct 2021
LinkedIn Corporate Company Profile

Company Milestones & Timeline

3 Events
  1. Capital Raise

    Raised $1,500,000 · Seed

    news.google.com

  2. Milestone

    Website domain registered

    perseveretherapeutics.com

  3. Milestone

    X account created (@PersevereTx)

    2.0K followers

Investors & Backers

Investor firms and individual backers were not publicly disclosed in available round filings for Persevere Therapeutics.

Funding History

1 Round
Seed equity · Mar 3, 2026

Founders & Leadership

1

Greg Bosch

Founder

Work email & phone locked Unlock →

Press Coverage & Sources

Recently Funded Biotech & Healthcare Startups

View all

Search the startup feeds free with 50 starter credits.

START FREE WITH 50 CREDITS
Recently funded startups
New SaaS launches
Never pay twice for contacts